Cortex Pharmaceuticals Inc. said Wednesday its stock has been removed from the Nasdaq SmallCap market. The shares, which have been trading below $1 since mid-October, will be traded on the low-profile over-the-counter market. The stock closed Wednesday at 44 cents a share, unchanged.
Irvine-based Cortex, a developer of therapies for neurological and psychiatric disorders, has lost money every year this decade.
